June Lee

June Lee

Director/Board Member at ELEDON PHARMACEUTICALS, INC.

Net worth: - $ as of 2026-05-30

60 year
Health Technology
Consumer Services
Finance

Profile

June Lee is on the board of Eledon Pharmaceuticals, Inc. and Chairman for Council of Korean Americans. In her past career she occupied the position of Chief Development Officer & Executive VP at MyoKardia, Inc., Medical Director of Genentech, Inc., Director-Translational Research & Catalyst Program at The University of California, San Francisco and Professor at California University of Science & Medicine. June Lee received an undergraduate degree from The Johns Hopkins University School of Medicine and a doctorate from UC Davis School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 0 ( -.--% ) - $ 2026-05-30
2026-05-27 0 ( -.--% ) - $ 2026-05-30
2026-02-27 0 ( -.--% ) - $ 2026-05-30

June Lee active positions

CompaniesPositionStart
ELEDON PHARMACEUTICALS, INC. Director/Board Member 2020-12-08
TENAYA THERAPEUTICS, INC. Director/Board Member 2021-11-18
ABIVAX Director/Board Member 2023-07-10
NKGEN BIOTECH KOREA CO., LTD. Director/Board Member 2025-11-20
Council of Korean Americans
Director/Board Member -
Director/Board Member -
University of California Drug Discovery Consortium
Chairman -

Former positions of June Lee

CompaniesPositionEnd
Private Equity Investor 2024-11-29
CINCOR PHARMA, INC. Director/Board Member 2023-02-23
░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of June Lee's experience

Training of June Lee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Consumer Services

Council of Korean Americans

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

University of California Drug Discovery Consortium

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!